GlassScriptPhysician profile
John J Hewett
NPI 1972543296
$58,244.17
in general payments reported to CMS, 2019-2025
27 companies · $8,940 in 2025
The $8,940 reported for 2025 was more than what 89% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $1,805 · 2021: $3,389 · 2022: $3,823 · 2023: $13K · 2024: $9,005 · 2025: $8,940.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $25K · Food and Beverage: $6,359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $25,000.00 |
| Food and Beverage | $6,358.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $27,274.87 | 2020-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Boston Scientific Corporation | $15,563.21 | 2019-2024 | |
| Siemens Medical Solutions USA, INC. | $8,771.96 | 2019-2025 | Artis Icono Floor, Cios Alpha, Artis Zee Multi-Purpose |
| Tactile Systems Technology INC | $1,718.58 | 2019-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Koya Medical, INC. | $830.13 | 2023-2025 | Dayspring, Dayspring, Koya Medical |
| Janssen Pharmaceuticals, INC | $793.54 | 2019-2024 | Xarelto |
| Medtronic, INC. | $688.85 | 2021-2024 | Venaseal, Abre |
| Organogenesis INC. | $622.51 | 2022-2024 | Puraply |
| Amgen INC. | $258.30 | 2023-2025 | Repatha, Repatha |
| Bard Peripheral Vascular, INC. | $257.98 | 2023-2025 | Lutonix Drug Coated Balloon, Wavelinq |
| Philips North America LLC | $226.88 | 2019 | |
| Becton, Dickinson and Company | $225.92 | 2025 | Lutonix Drug Coated Balloon |
| Cardiovascular Systems INC. | $193.76 | 2020-2023 | Diamondback Peripheral |
| Inari Medical, INC. | $137.82 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Lemaitre Vascular, INC. | $125.00 | 2023 | Artegraft Vascular Graft |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reflow Medical INC | $124.18 | 2025 | |
| Biotronik INC. | $95.76 | 2024-2025 | Pulsar-18 T3 |
| Abbott Laboratories | $66.29 | 2019-2024 | Diamondback Peripheral |
| Biowound Solutions, INC. | $53.64 | 2025 | Bio-Connekt |
| Cardiva Medical, INC. | $45.52 | 2021-2025 | Cardiva Vascade 6/7f Vcs |
| Nevro Corp. | $40.42 | 2023 | Senza |
| Novartis Pharmaceuticals Corporation | $37.91 | 2025 | |
| Avinger INC. | $24.85 | 2021 | |
| Sirtex Medical INC | $22.67 | 2024 | Sir-Spheres Microspheres |
| Bioventus LLC | $17.11 | 2023 | Durolane |
| Pfizer INC. | $14.10 | 2023 | |
| Veryan Medical Incorporated | $12.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hewett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.